Source:http://linkedlifedata.com/resource/pubmed/id/14769900
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
Pt 2
|
pubmed:dateCreated |
2004-2-10
|
pubmed:abstractText |
The role of interleukin (IL)-18 in the development of the host defence system against influenza virus infection was investigated. IL-18-deficient (IL-18(-/-)) C57BL/6 mice that were inoculated intranasally with the mouse-adapted strain of human influenza A/PR/8/34 (H1N1) virus showed an increased mortality with the occurrence of pathogenic changes in the lung for the first 3 days of infection, which included pronounced virus growth with massive infiltration of inflammatory cells and elevated nitric oxide production. The interferon-gamma (IFN-gamma) level induced in the respiratory tract of IL-18(-/-) mice in the first few days after virus infection was significantly lower but, in contrast, the IL-12 level was slightly higher than the corresponding levels in wild-type C57BL/6 mice. Natural killer (NK) cell-mediated cytotoxicity in the lung of IL-18(-/-) mice was poorly activated. Local immune responses in the lung such as specific cytotoxic T lymphocyte and antibody production were induced upon influenza virus infection equally well in both strains of mice. These results indicate that IL-18 is involved in controlling influenza virus replication in the lung, especially at an early stage of infection, through activation of the innate immune mechanisms such as IFN and NK cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-1317
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
85
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
423-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:14769900-Animals,
pubmed-meshheading:14769900-Bronchoalveolar Lavage Fluid,
pubmed-meshheading:14769900-Disease Models, Animal,
pubmed-meshheading:14769900-Influenza A virus,
pubmed-meshheading:14769900-Interferon-gamma,
pubmed-meshheading:14769900-Interleukin-12,
pubmed-meshheading:14769900-Interleukin-18,
pubmed-meshheading:14769900-Killer Cells, Natural,
pubmed-meshheading:14769900-Mice,
pubmed-meshheading:14769900-Mice, Inbred C57BL,
pubmed-meshheading:14769900-Mice, Knockout,
pubmed-meshheading:14769900-Nitric Oxide,
pubmed-meshheading:14769900-Orthomyxoviridae Infections,
pubmed-meshheading:14769900-Pneumonia,
pubmed-meshheading:14769900-Respiratory System
|
pubmed:year |
2004
|
pubmed:articleTitle |
Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity.
|
pubmed:affiliation |
Department of Microbiology, Fukui Medical University School of Medicine, Shimoaisuki 23-3, Matsuoka-cho, Yoshida-gun, Fukui 910-1193, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|